# Marginalized Frailty-Based Illness-Death Model: Application to the   UK-Biobank Survival Data

**Authors:** Malka Gorfine, Nir Keret, Asaf Ben Arie, David Zucker, Li Hsu

arXiv: 1906.03187 · 2021-03-16

## TL;DR

This paper introduces a novel semi-parametric illness-death model with shared frailty, tailored for UK Biobank data, to analyze genetic and environmental risk factors affecting disease and mortality, accounting for complex recruitment and data issues.

## Contribution

It develops a new semi-parametric illness-death model with shared frailty that handles delayed entry, prevalent and incident cases, and age restrictions in UK Biobank data.

## Key findings

- Effective estimation procedure for the new model
- Handles delayed entry and prevalent cases
- Applied to UK Biobank data for disease risk analysis

## Abstract

The UK Biobank is a large-scale health resource comprising genetic, environmental and medical information on approximately 500,000 volunteer participants in the UK, recruited at ages 40--69 during the years 2006--2010. The project monitors the health and well-being of its participants. This work demonstrates how these data can be used to estimate in a semi-parametric fashion the effects of genetic and environmental risk factors on the hazard functions of various diseases, such as colorectal cancer. An illness-death model is adopted, which inherently is a semi-competing risks model, since death can censor the disease, but not vice versa. Using a shared-frailty approach to account for the dependence between time to disease diagnosis and time to death, we provide a new illness-death model that assumes Cox models for the marginal hazard functions. The recruitment procedure used in this study introduces delayed entry to the data. An additional challenge arising from the recruitment procedure is that information coming from both prevalent and incident cases must be aggregated. Lastly, we do not observe any deaths prior to the minimal recruitment age, 40. In this work we provide an estimation procedure for our new illness-death model that overcomes all the above challenges.

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/1906.03187/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/1906.03187/full.md

## References

44 references — full list in the complete paper: https://tomesphere.com/paper/1906.03187/full.md

---
Source: https://tomesphere.com/paper/1906.03187